The trial demonstrated equivalence in the primary endpoint of objective response rate (ORR) of PF-05280014 versus Herceptin, taken in combination with paclitaxel, in first line patients with HER2-positive metastatic breast cancer. ORR is defined as the proportion of patients with tumor size reduction of a predefined amount and for a minimum period of time2. As the leading global biosimilars company, we are committed to advancing our robust pipeline of biosimilar therapies in hopes of expanding access to high-quality treatment options for patients living with serious, life-threatening conditions such as cancer, said Sumant Ramachandra, MD, PhD, MBA, Head of Research and Development, Pfizer Essential Health. Favorable comparative clinical data between proposed biosimilars and their respective reference product contribute to no data physician and patient understanding of and confidence in the value and importance of biosimilars. We are encouraged by these data and look forward to sharing the complete results with health authorities and the oncology community once available. A separate comparative, randomized, double-blind clinical trial [REFLECTIONS B3271004] in early breast cancer patients [N=226] also met its primary endpoint of steady-state Ctrough concentrations (PK) in patients treated with PF-05280014 and Herceptin. About the REFLECTIONS B3271002 Study REFLECTIONS B3271002 is a comparative, randomized, double blind, clinical trial[N=690] evaluating the efficacy, safety, pharmacokinetics (PK) and immunogenicity of PF-05280014 (a potential biosimilar to Herceptin [trastuzumab]) in combination with paclitaxel versus Herceptin in combination with paclitaxel in first line patients with HER2-positive metastatic breast cancer. The primary endpoint is objective response rate (ORR) by Week 25 of study treatment. ORR is defined as the proportion of patients with tumor size reduction of a predefined amount and for a minimum period of time2. More information about the PF-05280014 REFLECTIONS B3271002 and B3271004 studies can be found at www.clinicaltrials.gov . About PF-05280014 PF-05280014 is a monoclonal antibody (mAb) that is in development as a potential biosimilar for all currently approved indications of Herceptin (trastuzumab). Herceptin is currently approved in the U.S., EU and other markets for HER2-positive breast cancer and gastric cancer.
For the original version including any supplementary images or video, visit http://finance.yahoo.com/news/pfizer-announces-positive-top-line-133000188.html
Ra uses every free minute he gets to tinker … – Could you describe a difficult problem and how you dealt with it? After reading your guide, I said oh my God, my answers were wrong in my previous interview. For young Ra, who lives in a shabby suburb of London with his unemployed and permanently drunk father Mario, motorbike riding is everything. All the questions and all the answers that you had in the guide is exactly word-by-word what I got asked. Prior to that, I went to five interviews, got nothing, went to this one and landed a job. “I meet deadlines. “I have a solid background in Accounts Receivables, great problem solving abilities and I get things done with little direction.” 2. I would have had so much less stress. Did you have any trouble finding the office?
All in all, the role of MPs and PAs is fairly similar. Some courses may demand a certain amount of work experience before they are eligible for the program. Infectious Disease Specialist – Studies and treats diseases that are caused by viruses, bacteria, fungi and parasites. Definition: A registered nurse trained to be a primary healthcare provider. A paediatrician’s salary ranges from US$87,100 to US$203,391. The website PayScale reports that a PAC may earn anywhere between US $67,000 and US $105,000. Well, now that you’ve set your heart and soul to pursue any of the large number of medical careers and related medical jobs around, let’s go through a list and check out the earning potential of each of these medical careers. Endodontist – Undertakes treatment for root canal, dental trauma, cracked teeth and endodontic surgeries. Some nurse practitioners may use their training, experience, and education to counsel and interview skills blog educate people about leading a healthy lifestyle and preventing diseases.
<img src="http://www1.pictures.zimbio.com/pc/Michelle+Williams+celebrates+33rd+birthday+fGp_BCi-h7ex.jpg" width='250px' alt='Michelle Williams medical interview tsr Opens Up About Raising Daughter Matilda Without Heath Ledger in New Interview’ align=’left’ /> “In pretty much all senses but one. I would be able to go totally down that line of thinking were it not for Matilda not having her dad. You know, that’s just something that doesn’t…I mean, it just won’t ever be right.” Pacific Coast News Williams went on to say she never imagined herself as a single lady in her mid-thirties. “Talk about a learning process,” she shared. “I think…God, what would I say about no data it? I feel really sensitive about it and certainly did not expect to still be dating at 36 with an 11-year-old.” “I’m like a cat, I’m a very domestic creature,” Williams continued. “I just want to stay home and take care of people. But I’m also happy with myself and just because I might have a desire to be with someone…that won’t lead me to marry the wrong person.” Williams and Ledger met on the set of Brokeback Mountain in 2004, bringing Matilda into the world the following year. In September of 2007, the two ended their three-year relationship amicably. Ledger passed four months later.
For the original version including any supplementary images or video, visit http://www.zimbio.com/Michelle+Williams/articles/QSEQ6QoY9U1/Michelle+Williams+Opens+Up+Raising+Daughter